SCHEDULE: Davis Advisers Updates Viatris Stake to 6.5%

Davis Selected Advisers has updated its Schedule 13G filing, reporting beneficial ownership of 75,232,254 shares, representing 6.5% of Viatris Inc.'s common stock.

Summary

• Davis Selected Advisers has filed an amendment (No. 8) to its Schedule 13G, reporting its beneficial ownership of Viatris Inc. common stock.
• The filing indicates that as of June 30, 2026, Davis Selected Advisers beneficially owns 75,232,254 shares of Viatris Inc. common stock.
• This ownership represents approximately 6.5% of the class of securities.
• The filing confirms sole voting power over 72,567,897 shares and sole dispositive power over 75,232,254 shares.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily an update on beneficial ownership without significant new strategic or financial information.

Positives

• Davis Selected Advisers maintains a significant stake in Viatris Inc., indicating continued confidence in the company.
• The filing confirms a substantial number of shares (75,232,254) are held, representing 6.5% of the class.

Negatives

• No new financial performance data or strategic initiatives are disclosed in this filing, limiting insight into the company's current operational health.

Risks

• The filing does not contain specific risk factors; however, any investment in Viatris Inc. is subject to the general risks outlined in the company's other SEC filings.

Future Outlook

This filing is an update on beneficial ownership and does not contain forward-looking statements or specific future guidance from Viatris Inc.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures for institutional investors crossing certain ownership thresholds. This update from Davis Selected Advisers indicates their ongoing role as a significant shareholder in the pharmaceutical sector, specifically within Viatris Inc.

Stakeholder Impact

• Shareholders: The filing confirms a major institutional investor's holdings, which can influence market perception and trading activity.
• Viatris Inc.: The continued significant ownership by Davis Selected Advisers suggests a stable, albeit passive, institutional support.

Next Steps

• Davis Selected Advisers will continue to file amendments to Schedule 13G as required by SEC regulations based on changes in their beneficial ownership of Viatris Inc. securities.

Key Dates

Keywords

Viatris Inc., Schedule 13G, Beneficial Ownership, Davis Selected Advisers, Common Stock, Investment Management